|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| (11) | Number of the document | 1948133 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06802424.9 |
| Date of filing the European patent application | 2006-08-28 | |
| (97) | Date of publication of the European application | 2008-07-30 |
| (45) | Date of publication and mention of the grant of the patent | 2011-06-29 |
| (46) | Date of publication of the claims translation | 2011-08-25 |
| (86) | Number | PCT/US2006/033432 |
| Date | 2006-08-28 |
| (87) | Number | WO 2007/027565 |
| Date | 2007-03-08 |
| (30) | Number | Date | Country code |
| 713403 P | 2005-09-01 | US |
| (72) |
OWOO, George, US
BURGOS, Richard A., US
|
| (73) |
Baxter Healthcare S.A.,
Thurgauerstrasse 130, 8152 Glattpark (Opfikon),
CH
BAXTER INTERNATIONAL INC. (a Delaware corporation), One Baxter Parkway, Deerfield Illinois 60015, US |
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
| (54) | Argatrobano kompozicija, apimanti rūgštį kaip soliubilizatorių |
| ARGATROBAN FORMULATION COMPRISING AN ACID AS SOLUBILIZER |
| Payment date | Validity (years) | Amount | |
| 2013-07-31 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-08-28 |